RUNX1 and chronic myelogenous leukemia, BCR-ABL1 positive: It has already been acknowledged that expression levels of EVI1 are of prognostic value in different cancer types, including hematologic malignancies like AML32 and CML,38 as well as solid cancers such as prostate48 and ovarian cancer,44 suggesting that EVI1 expression levels might also be informative to navigate and improve treatment strategies of EVI1high malignancies in the future.